Close
  Indian J Med Microbiol
 

Figure 2: Tumor volume of growth over time with different treatments and quantification 7 d after treatment. A: Quantification of tumor-derived bioluminescence as an approxima-tion of in vivo tumor volume over time for different treatment groups. B: Quantification of tumor-derived bioluminescence as an approximation of in vivo tumor volume 7 d after the last treatment. VC: vehicle control group; DE-rhCNB, rhCNB dose-escalation group; H/M/L-rhCNBrhCNB/L-rhCNB, rhCNB high/medium/low-dose injection group; HCPT, hydroxycamptothecin injection positive control group; rhIL-2, recombinant human interleukin-2.

Figure 2: Tumor volume of growth over time with different treatments and quantification 7 d after treatment. A: Quantification of tumor-derived bioluminescence as an approxima-tion of <i>in vivo</i> tumor volume over time for different treatment groups. B: Quantification of tumor-derived bioluminescence as an approximation of <i>in vivo</i> tumor volume 7 d after the last treatment. VC: vehicle control group; DE-rhCNB, rhCNB dose-escalation group; H/M/L-rhCNBrhCNB/L-rhCNB, rhCNB high/medium/low-dose injection group; HCPT, hydroxycamptothecin injection positive control group; rhIL-2, recombinant human interleukin-2.